i&i Biotech Fund
Karel Kubias is a seasoned professional in the biotech and management sectors, currently serving as a Partner at i&i Biotech Fund since September 2021. Prior to this role, Karel held the position of Director for Partnerships and Strategic Alliances at i&i Prague, where focus was on identifying and promoting promising biotech projects in Central Europe. Academic contributions include serving as Chair of the Department of Management and Lecturer of Business Ethics at Anglo-American University in Prague. Karel's extensive experience also encompasses leadership positions at EUC a.s. and Merck Millipore, where responsibilities included managing Life Science operations across multiple regions and overseeing business activities in the Czech market. Karel's educational background includes a degree in Chemistry from Technische Hochschule Carl Schorlemmer Merseburg and an MBA in Healthcare Management from Auburn University, among other qualifications.
This person is not in any teams
This person is not in any offices
i&i Biotech Fund
i&i Bio is a Luxembourg-based venture capital firm that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics and digital health. With over €53M under management, i&i Bio plans to invest in about 20 early-stage companies. i&i Bio is led by an experienced team of professionals with backgrounds in private equity, the healthcare industry and venture capital who support entrepreneurs on their journey to global success. Thanks to close cooperation with the fund’s main sponsor, the biotech academic incubator, i&i Prague, i&i Bio has a great opportunity to be at the inception of transformative Central European technologies.